Atlas Trials

R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma

Clinical trial NCT02428751 · UNKNOWN

Trial details

NCT number
NCT02428751
Sponsor
Wenqi Jiang
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma, Large B-Cell, Diffuse
Start date
2015-09-01
Primary completion
2020-03-01
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.